AGFAF supports the education of young Afghan women who wish to use the education and leadership skills they develop while studying in the US to improvre the lives of women and families in Afghanistan.

Broad range of assistance to CEO on issues of firm management, operations, growth and direction. Also, strategic advisor to Plane Tree Capital (UK) and its Carbon Assets Fund II.

Founding Partner, ENVIRON International Corporation (1982-85)Consultant on issues of chemical risk management.Managing Partner, ENVIRON International Corporation - Princeton Office (1985-90) Responsible for the successful operations, growth and development of ENVIRON’s Princeton business unit. Consultant on issues of chemical risk management; President, ENVIRON Holdings Inc. (1990-91)Corporate oversight of ENVIRON Holdings Inc.’s operations. Direct responsibility for working with business unit managers and insuring successful operational performance. Consultant on issues of chemical risk management; CEO, ENVIRON Holdings Inc (1991-2007) Overall responsibility for Company’s strategic growth, development and operations. After completing an MBO in 1999, ENVIRON has been an industry leader achieving growth in revenues and operating profits in excess of 20% per year and a 45 fold increase in share value. In 2007, ENVIRON’s net revenues exceeded $160 million with 1,100 employees in 14 countries around the world. Dr. Highland was directly responsible for much of the senior recruiting and all transactional initiatives that supported ENVIRON’s significant international growth. Chief negotiator with outside firms including acquisition targets, and Private Equity firms Over his last 5 years as CEO, Dr. Highland helped lead ENVIRON’s efforts to develop CDM and JI projects under the Kyoto Protocol as part of ENVIRON’s Climate Change initiative. He also headed the development of ENVIRON’s program in Corporate Social Responsibility

Providing a broad range of business consulting services to a variety of clients in the environmental engineering and consulting industry. In addition, significant assignment with Aprecia Pharmaceuticals helping direct operational and strategic initiatives including achieving the next round of financing from Private Equity, strategic partners and/or a key customer.

Working with members of the EFCG team to assist clients with a variety of business issues including operations, strategic development and sustainability practice and services.